Trending News
Search results for: "Weight loss". 8 articles found.
Bid to improve access to Mounjaro in England, but experts warn eligibility still tightly restricted.
Kelly Osbourne fires back at cruel body shaming comments on social media after London Fashion Week appearance and calls trolls "disgusting human beings."...
Retraction Watch - 9 hours 44 min agoAfter reading a recent study about GLP-1 treatment in the International Journal of Obesity, David B. Allison immediately became skeptical about the paper's analysis. The article, published in May 2024, found people who combined a GLP-1 therapy with another weight loss drug added to GLP-1 therapy led to greater weight loss in patients. "I … Continue reading Journal retracts GLP-1 study after researcher questions central finding...
GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines.
Novo's CagriSema shot was shown to be less effective than rival Lilly's tirzepatide...
Novo Nordisk's shares fall sharply after testing of CagriSema falls short of investors' expectations Business live latest updates The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled "obsolete" after disappointing clinical trials. Novo Nordisk's shares fell sharply on Monday after the results from testing the Danish company's CagriSema drug fell short of investors' expectations. Continue reading...
Novo Nordisk just learned its latest much-hyped obesity drug may not actually live up to the hype. Shares of the Danish pharma giant plunged 16% Monday after it reported that its experimental drug, CagriSema, did not match the weight loss achieved by Eli Lilly's rival drug in a direct comparison...
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target.
GET IN TOUCH
About
Snips is the first performance-based influencer marketing platform that empowers influencers with business tools to grow their audience and monetize their social networks, while enabling brands to run performance-driven influencer programs built on true measurability & scale.